Aker BioMarine ASA (OSL:AKBM)
Norway · Delayed Price · Currency is NOK 110.00
+6.00 (5.77%)
Jul 31, 2026, 4:25 PM CET
Aker BioMarine ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,647 | 8,686 | 5,912 | 3,997 | 3,341 | 4,757 | |
Market Cap Growth | 41.75% | 46.91% | 47.91% | 19.64% | -29.76% | -54.34% |
Enterprise Value | 11,481 | 10,353 | 7,421 | 7,716 | 6,848 | 7,523 |
Last Close Price | 110.00 | 99.03 | 67.43 | 45.59 | 38.12 | 54.31 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 35.47 | - |
Forward PE | 32.21 | 39.34 | 179.33 | 80.58 | 30.13 | 192.08 |
PS Ratio | 4.29 | 3.95 | 2.61 | 2.00 | 1.23 | 2.06 |
PB Ratio | 7.17 | 5.98 | 3.12 | 1.07 | 0.90 | 1.46 |
P/TBV Ratio | 636.99 | 321.68 | 137.17 | 18.93 | 15.47 | 23.90 |
P/FCF Ratio | - | - | - | 261.92 | - | - |
P/OCF Ratio | - | 205.00 | 42.56 | 8.29 | 22.64 | 207.48 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.10 | 4.71 | 3.27 | 3.86 | 2.53 | 3.26 |
EV/EBITDA Ratio | 81.36 | 28.67 | 14.95 | 18.10 | 9.53 | 21.71 |
EV/EBIT Ratio | 81.36 | 80.18 | - | - | 31.71 | - |
EV/FCF Ratio | - | - | - | 505.58 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.31 | 1.11 | 0.84 | 0.94 | 0.88 | 0.79 |
Debt / EBITDA Ratio | 13.75 | 5.09 | 3.38 | 9.38 | 5.19 | 8.27 |
Debt / FCF Ratio | - | - | - | 262.00 | - | - |
Net Debt / Equity Ratio | 1.36 | 1.15 | 0.80 | 1.00 | 0.95 | 0.85 |
Net Debt / EBITDA Ratio | 12.42 | 4.62 | 3.04 | 8.72 | 4.88 | 7.98 |
Net Debt / FCF Ratio | -31.37 | -78.71 | -25.48 | 243.67 | -14.13 | -4.12 |
Asset Turnover | 0.58 | 0.57 | 0.33 | 0.24 | 0.35 | 0.36 |
Inventory Turnover | 1.08 | 1.22 | 0.88 | 0.65 | 0.97 | 1.38 |
Quick Ratio | 0.92 | 0.85 | 1.32 | 0.88 | 0.87 | 1.15 |
Current Ratio | 2.60 | 2.57 | 3.66 | 2.57 | 2.85 | 3.10 |
Return on Equity (ROE) | -7.22% | -1.80% | -4.50% | -8.67% | 2.67% | -2.15% |
Return on Assets (ROA) | 3.99% | 3.33% | -0.69% | -1.26% | 2.29% | -2.03% |
Return on Invested Capital (ROIC) | 4.91% | 4.21% | -0.81% | -1.42% | 2.55% | -2.30% |
Return on Capital Employed (ROCE) | 4.73% | 4.01% | -0.81% | -1.45% | 3.16% | -2.09% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | - | - | 2.82% | - |
FCF Yield | - | - | - | 0.38% | - | - |
Dividend Yield | - | 0.00% | 71.89% | 0.00% | 0.00% | 0.00% |
Payout Ratio | - | 0.00% | 204.38% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | -143.60% | -0.02% | -0.02% | -0.04% | -0.05% | -12.20% |
Total Shareholder Return | -143.60% | -0.02% | 71.86% | -0.04% | -0.05% | -12.20% |